0.6110EUR0.00%Mkt Cap: 51.92M $P/E: —2d ago
Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, and internationally. The company offe…
Indicators:|
Key Statistics
Company
Market Cap51.92M $
Enterprise Value75.05M $
Revenue (TTM)0 $
Gross Profit85.93K $
Net Income (TTM)-48.54M $
Revenue/Share0.0000 USD
Last Price0.6110 EUR
Fiscal Year EndDec 2024
MR QuarterJun 2025
Employees48
CountryBE
SectorHealthcare
IndustryMedical Devices
ISINBE0974340722
Valuation
P/E (Trailing)—
P/E (Forward)-1.67
PEG—
EV/EBITDA-4.01
EV/Revenue—
P/SInfinity
P/B-0.89
EPS (TTM)-1.23
EPS (Forward)-0.36
52W Range
0.460013% of range1.618
52W High1.618 EUR
52W Low0.4600 EUR
Profitability
Gross Margin74.94%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin-42325.70%
ROE100.62%
ROA-449.06%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-22.02M $
CapEx (TTM)103.40K $
FCF Margin—
FCF Yield-27.24%
Net Debt37.05M $
Net Debt/EBITDA-1.98
Balance Sheet
Debt/Equity-0.90
Current Ratio0.20
Quick Ratio0.15
Book Value/Sh-0.6850 EUR
Cash/Share0.1280 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating0.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.78.17M
Float34.99M
Insiders13.16%
Institutions28.93%
Technical
SMA 500.6052 (+1.0%)
SMA 2000.6251 (-2.3%)
Beta-0.29
S&P 52W Chg20.05%
Avg Vol (30d)0
Avg Vol (10d)0
Technical Indicators
RSI (14)68.9
MACD0.0032
MACD Signal0.0046
MACD Hist.-0.0014
BB Upper0.6110 EUR
BB Middle0.6110 EUR
BB Lower0.6110 EUR
BB Width0.00%
ATR (14)0.0018 EUR
Vol Ratio (20d)—